Pierpaolo Alongi
Pierpaolo Alongi
Nuclear Medicine Unit - San Raffaele G.Giglio Institute
Email verificata su hsrgiglio.it
Titolo
Citata da
Citata da
Anno
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT
P Alongi, M Picchio, F Zattoni, M Spallino, L Gianolli, G Saladini, ...
European journal of nuclear medicine and molecular imaging 43 (3), 464-473, 2016
482016
18F-Fluoroethylcholine (18F-Cho) PET/MRI Functional Parameters in Pediatric Astrocytic Brain Tumors.
BJB Fraioli F, Shankar A, Hargrave D, Hyare H, Gaze MN, Groves AM, Alongi P ...
Clinical Nuclear Medicine, 2014
40*2014
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: case report and literature review
F Alongi, A Bolognesi, AMS Gajate, M Motta, C Landoni, G Berardi, ...
Tumori Journal 96 (2), 322-326, 2010
332010
A cross-validation of FDG-and amyloid-PET biomarkers in mild cognitive impairment for the risk prediction to dementia due to Alzheimer’s disease in a clinical setting
L Iaccarino, K Chiotis, P Alongi, O Almkvist, A Wall, C Cerami, V Bettinardi, ...
Journal of Alzheimer's Disease 59 (2), 603-614, 2017
322017
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study
F Caobelli, P Alongi, L Evangelista, M Picchio, G Saladini, M Rensi, ...
European journal of nuclear medicine and molecular imaging 43 (3), 404-413, 2016
312016
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu’s arteritis
E Incerti, E Tombetti, F Fallanca, EM Baldissera, P Alongi, E Tombolini, ...
European Journal of Nuclear Medicine and Molecular Imaging 44 (7), 1109-1118, 2017
302017
Radiation treatment of lymph node recurrence from prostate cancer: is 11C-choline PET/CT predictive of survival outcomes?
E Incerti, A Fodor, P Mapelli, C Fiorino, P Alongi, M Kirienko, ...
Journal of Nuclear Medicine 56 (12), 1836-1842, 2015
302015
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonizationá…
F Fallanca, P Alongi, E Incerti, L Gianolli, M Picchio, I Kayani, J Bomanji
European journal of nuclear medicine and molecular imaging 43 (10), 1837-1848, 2016
272016
Evaluation of an optimized [18F]fluoro‐deoxy‐glucose positron emission tomography voxel‐wise method to early support differential diagnosis in atypicalá…
SP Caminiti, P Alongi, L Majno, MA VolontŔ, C Cerami, L Gianolli, G Comi, ...
European Journal of Neurology 24 (5), 687-e26, 2017
222017
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT
P Alongi, F Caobelli, R Gentile, A Stefano, G Russo, D Albano, S Baldari, ...
European journal of nuclear medicine and molecular imaging 44 (2), 224-233, 2017
212017
Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies-a multicenter experience.
A Cistaro, AA Niccoli, P Coppolino, N Quartuccio, C Altini, M Cucinotta, ...
Hellenic journal of nuclear medicine 18 (2), 97-102, 2015
212015
The role of PET/CT in the evaluation of patients affected by limbic encephalitis: A systematic review of the literature
N Quartuccio, F Caobelli, L Evangelista, P Alongi, M Kirienko, V De Biasi, ...
Journal of Neuroimmunology 284, 44-48, 2015
202015
PET Neuroimaging: Insights on Dystonia and Tourette syndrome and potential applications
P Alongi, L Iaccarino, D Perani
Movement Disorders, 0, 2014
162014
Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis
A Dodich, C Cerami, S Iannaccone, A Marcone, P Alongi, C Crespi, ...
Brain and Cognition 108, 81-87, 2016
152016
18F-FDG PET/CT for early postradiotherapy assessment in solitary bone plasmacytomas
P Alongi, L Zanoni, E Incerti, F Fallanca, P Mapelli, N Papathanasiou, ...
Clinical nuclear medicine 40 (8), e399-e404, 2015
152015
Whole body magnetic resonance in indolent lymphomas under watchful waiting: the time is now
M Galia, D Albano, C Tarella, C Patti, LM Sconfienza, A MulŔ, P Alongi, ...
European Radiology 28 (3), 1187-1193, 2018
122018
[11C]choline-PET-guided Helical Tomotherapy and Estramustine in a Patient with Pelvic-Recurrent Prostate Cancer: Local Control and Toxicity Profile after 24á…
F Alongi, S Schipani, AMS Gajate, A Rosso, C Cozzarini, C Fiorino, ...
Tumori Journal 96 (4), 613-617, 2010
112010
Imaging features of adrenal masses
D Albano, F Agnello, F Midiri, G Pecoraro, A Bruno, P Alongi, P Toia, ...
Insights into imaging 10 (1), 1-16, 2019
102019
Megavoltage CT images of helical tomotherapy unit for radiation treatment simulation: impact on feasibility of treatment planning in a prostate cancer patient with bilateralá…
F Alongi, A Fodor, A Maggio, C Cozzarini, C Fiorino, S Broggi, P Alongi, ...
Tumori Journal 97 (2), 221-224, 2011
102011
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art
F Caobelli, L Evangelista, N Quartuccio, D Familiari, C Altini, A Castello, ...
World journal of radiology 8 (10), 829, 2016
92016
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20